Introduction {#s1}
============

The neck is composed of approximately 80 skeletal muscles in humans that allow head mobility, respiration, swallowing and vocalization processes, containing essential elements such as the trachea, esophagus, larynx, and cervical vertebrae. These processes are ensured by a robust network of muscles at the head-trunk interface, a transition zone subjected to a spectrum of human muscle diseases such as dropped head syndrome, oculopharyngeal myopathy, myotonic dystrophy, Duchenne-type dystrophy and congenital muscular disorders ([@bib14]; [@bib47]; [@bib69]). Defining the embryology of these distinct muscle groups is critical to understand the mechanisms underlying the susceptibility of specific muscles to muscular dystrophies. While myogenesis at the cranial and trunk levels has been studied extensively, the developmental mechanisms at the basis of neck muscle formation are poorly documented and often debated ([@bib17]).

In vertebrates, head and trunk muscles arise from different mesodermal origins and their development depends on distinct myogenic programs. At the cranial level, the cardiopharyngeal mesoderm (CPM) resides in pharyngeal arches and gives rise to branchiomeric muscles and the second heart field. CPM specification is initiated by the activation of genes such as *Mesp1*, *Islet1* and *Tbx1,* while *Pax7* subsequently marks muscle stem cells ([@bib11]; [@bib33]; [@bib54]; [@bib72]; [@bib76]). In contrast, *Pax3* and *Pax7* are expressed in somitic mesoderm giving rise to trunk and limb muscles, with *Pax3* then being downregulated in most muscles during fetal stages, while *Pax7* maintains the stem cell pool ([@bib32]; [@bib71]; [@bib86]). After the differential specification of cranial and trunk progenitors, the bHLH myogenic regulatory factors (MRFs) Myf5, Mrf4, Myod and Myog regulate myogenic cell fate and differentiation (reviewed in \[[@bib7]; [@bib59]\]).

In early embryos, *Tbx1* is required for robust activation of MRF genes and proper branchiomeric muscle formation ([@bib21]; [@bib33]; [@bib34]; [@bib76]). In *Tbx1* mutant embryos, the first pharyngeal arch is hypoplastic and posterior pharyngeal arches do not form resulting in variably penetrant defects of masticatory muscles and absence of muscles derived from more posterior arches ([@bib33]; [@bib40]; [@bib88]). In humans, *TBX1* is a major gene involved in 22q11.2 deletion syndrome (DiGeorge/velo-cardio-facial syndrome), a congenital disease characterized by cardiovascular defects and craniofacial malformations ([@bib62]). In contrast, *Pax3* acts upstream of MRF genes in somites and *Pax3* mutants have defects of epaxial and hypaxial muscle formation while double *Pax3/Pax7*-null embryos lack trunk/limb muscles ([@bib3]; [@bib71]; [@bib86]; [@bib89]).

The neck constitutes a transition zone characterizing land vertebrates (tetrapods). The major muscle groups in the neck consist of: epaxial back muscles; ventral hypaxial musculature; pharyngeal, laryngeal and esophagus striated muscles located medioventrally; and cucullaris-derived muscles. The cucullaris is a generic term defining putative homologous muscles that are evolutionarily conserved and connect the head and trunk in jawed vertebrates (gnathostomes). In amniotes, the cucullaris represents the embryonic anlage that gives rise to trapezius and sternocleidomastoid muscles which are innervated by the accessory nerve XI ([@bib10]; [@bib13]; [@bib17]; [@bib36]; [@bib37]; [@bib44]; [@bib84]).

While the somitic origin of epaxial/hypaxial neck muscles and CPM origin of pharyngeal, laryngeal and esophagus striated muscles are well defined ([@bib19]; [@bib57]; [@bib83]), the embryological origin of cucullaris-derived muscles has remained a subject of controversy ([@bib8]; [@bib13]; [@bib20]; [@bib27]; [@bib28]; [@bib48]; [@bib57]; [@bib64]; [@bib66]). This muscle group was reported to originate either from lateral plate mesoderm (LPM) or CPM populations adjacent to the first three somites in chick and axolotl ([@bib52]; [@bib80]; [@bib88]). However, retrospective lineage analysis indicated that the murine trapezius and sternocleidomastoid muscles are clonally related to second heart-field-derived myocardium and laryngeal muscles, consistent with a CPM origin ([@bib40]). Moreover, cucullaris development follows a branchiomeric program and cucullaris-derived muscles were shown to be absent in *Tbx1*-null mice ([@bib33]; [@bib40]; [@bib80]; [@bib88]). Nevertheless, the source of the cucullaris is still equivocal due to the location of its embryonic anlagen at the interface of cranial, somitic and lateral plate mesodermal populations.

Skeletal elements and muscle-associated connective tissue (MCT) also have distinct embryological origins along the rostro-caudal axis. The connective tissue of branchiomeric and tongue muscles originate from neural crest cells (NCCs) of cranial origin ([@bib18]; [@bib35]; [@bib57]; [@bib58]; [@bib98]). Cranial NCCs also give rise to skeletal components and tendons in the head. In contrast, the skeleton and connective tissue originate from somitic mesoderm in the trunk and from LPM in limbs ([@bib53]). The neck and shoulder girdle contain skeletal elements and connective tissues of distinct NCC, LPM or somitic origins ([@bib12]; [@bib48]; [@bib49]; [@bib52]; [@bib83]; [@bib90]). It has been suggested that NCCs form both connective tissue and endochondral cells at the attachment sites of neck muscles to shoulders in mouse ([@bib48]). However, studies in non-mammalian animals have contested a NCC contribution to the pectoral girdle ([@bib16]; [@bib31]; [@bib67]).

Therefore, the neck region consists of muscle, skeletal and connective tissue elements of mixed cellular origins, underscoring the difficulty in assigning embryonic identities for these structures. In addition, the genetic requirements for the formation of non-somitic and somitic neck muscles remain to be defined. To resolve these issues, we used genetic lineage and loss-of-function mice combined with histology, µCT and 3D reconstructions to map the embryological origins of all neck muscles and associated connective tissues. In doing so, we show that cucullaris-derived muscles originate from a posterior CPM population and are differentially affected in *Tbx1*-null mice. Moreover, we identify a unique genetic network involving both *Mesp1* and *Pax3* genes for somite-derived neck muscles and we define a new limit of neural crest contribution to neck connective tissue and shoulder components.

Results {#s2}
=======

Distinct myogenic programs define neck muscle morphogenesis {#s2-1}
-----------------------------------------------------------

To investigate the embryological origin of neck muscles in the mouse, we mapped CPM- and somite-derived myogenic cells using lineage-specific *Cre* drivers including *Mef2c-AHF*, *Islet1*, *Mesp1* and *Pax3* ([Figure 1](#fig1){ref-type="fig"}). The *Mef2c-AHF* (anterior heart field) enhancer is activated in the second heart field and myogenic progenitors of CPM origin ([@bib39]; [@bib91]). *Islet1* and *Mesp1* genes are both expressed in early CPM and are essential for cardiac development. The *Mesp1* lineage also marks some anterior somitic derivatives ([@bib5]; [@bib26]; [@bib75]; [@bib74]). In contrast, *Pax3* is activated in all somitic progenitors and is a key actor during trunk and limb muscle formation ([@bib71]; [@bib86]; [@bib89]). Given that the majority of *Mef2c-AHF* derivatives are myogenic cells ([@bib40]; [@bib39]; [@bib91]), we analyzed this lineage using *Rosa26^R-lacZ/+^* (*R26R*) reporter mice. *Islet1*, *Mesp1* and *Pax3* genes are also expressed in cells contributing to skeletal components, connective tissues or neurons. To focus on the myogenic lineage, we used *Pax7^nGFP-stop/nlacZ^* (*Pax7^GPL^*) reporter mice, which mark cells with nuclear β-galactosidase (β-gal) activity following *Cre* recombination ([@bib77]).

![Genetic lineage tracing of neck muscle progenitors.\
Whole-mount X-gal stainings of *Mef2c-AHF^Cre^;R26R*, *Islet1^Cre^;Pax7^GPL^*, *Mesp1^Cre^;Pax7^GPL^* and *Pax3^Cre^;Pax7^GPL^* mice at E10.5 (**A--D**), E11.75 (**E--H**) and E18.5 (**I--L'**) (n = 3 for each condition). See associated [Figure 1---supplements 1](#fig1s1){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. (**A--H**) Note labeling of mesodermal core of pharyngeal arches (PAs) and cucullaris anlage (ccl) by *Mef2c-AHF, Islet1* and *Mesp1* lineage reporters; β-gal^+^ cells in anterior somites of *Mesp1^Cre^* embryos and in the *clp* anlagen of *Islet1^Cre^* embryos. *Pax3* lineage marked somitic mesoderm. (**I--L'**) *Mef2c-AHF, Islet1* and *Mesp1* lineages marked branchiomeric (mas, tpr, dg) and cucullaris muscles (stm, atp and stp). *Pax3^Cre^* and *Mesp1^Cre^* labeled somitic epaxial neck muscles (epm). atp, acromiotrapezius; ccl, cucullaris anlage; clp, cutaneous maximus/latissimus dorsi precursor; dg, digastric; epm, epaxial musculature; h, heart; hc, hypoglossal cord; lbm, limb muscle anlagen and limb muscles; ltd, latissimus dorsi; mas, masseter; nc, nasal capsule; nt, neural tube; PA1-2, pharyngeal arches 1--2; S3, somite 3; stm, sternocleidomastoid; stp, spinotrapezius; tpr; temporal. Scale bars: in D for A-D and in H for E-H, 1000 µm; in L for I-L', 2000 µm.](elife-40179-fig1){#fig1}

We first examined embryos after myogenic specification (E10.5 and E11.75), and fetuses when muscles are patterned (E18.5). In *Mef2c-AHF^Cre^;R26R* embryos, β-gal-positive cells were observed in the mesodermal core of pharyngeal arches at the origin of branchiomeric muscles, in second heart field derivatives, and in the cucullaris anlage ([Figure 1A,E](#fig1){ref-type="fig"}). A spatiotemporal analysis of the cucullaris using *Myf5^Cre^;Pax7^GPL^* and *Myf5^Cre^;R26^mTmG^* embryos ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) showed that *Myf5*-derived muscle progenitors located at the level of the posterior pharyngeal arches, and adjacent to somites S1-S3 ([Figure 1---figure supplement 1A'](#fig1s1){ref-type="fig"}), were innervated by the accessory nerve XI ([Figure 1---figure supplement 1G--G"](#fig1s1){ref-type="fig"}). These cells gave rise to the trapezius and sternocleidomastoid muscles ([Figure 1---figure supplement 1A--F'](#fig1s1){ref-type="fig"}) thus confirming the identity of the cucullaris anlage in mouse ([@bib84]).

In *Islet1^Cre^;Pax7^GPL^* and *Mesp1^Cre^;Pax7^GPL^* embryos, labeling was also observed in pharyngeal arch derivatives and the cucullaris ([Figure 1B--C,F--G](#fig1){ref-type="fig"}), the latter showing less contribution from the *Islet1* lineage. On sections, a subset of the Myod-positive cells in the cucullaris originated from *Islet1*-derived cells ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Surprisingly, *Pax3^Cre^;Pax7^GPL^* embryos also showed *lacZ* expression in the cucullaris at E11.75, although no expression was detected at E10.5 ([Figure 1D,H](#fig1){ref-type="fig"}). Given that *Pax3* and *Pax7* are also expressed in neural crest cells ([@bib70]), and that these *Pax3/Pax7*-derived cells were excluded from the Myod-positive myogenic population at E12.5 after muscle specification ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}), they are likely to be of NCC origin. As expected, *Pax3* lineage tracing also labeled the somite-derived myotomes, hypaxial migrating progenitors that form the hypoglossal cord (origin of tongue and infrahyoid muscles), and limb muscle progenitors. Furthermore, the hypaxial anlage, which is located at the proximal limb bud and gives rise to the cutaneous maximus and latissimus dorsi muscles, was *Pax3*-derived ([Figure 1D,H](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1D'](#fig1s1){ref-type="fig"}) ([@bib68]; [@bib89]). Unexpectedly, this anlage and the latissimus dorsi muscle were also labeled in *Islet1^Cre^;Pax7^GPL^* but not in *Mesp1^Cre^;Pax7^GPL^* embryos ([Figure 1F--G,J--K](#fig1){ref-type="fig"}). On sections at E12.5, Islet1 expression was observed in *Pax3*-derived cells after the emergence of myogenic cells from the proximal limb bud ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). In addition, the *Mesp1* lineage contributed to anterior somitic derivatives during early embryonic development as previously reported ([@bib41]; [@bib74]); strong *lacZ* expression was observed in the hypoglossal cord and somites S1-S6. Labeling decreased in more posterior myotomes and in forelimb muscle progenitors compared to *Pax3^Cre^;Pax7^GPL^* embryos ([Figure 1C--D,G--H](#fig1){ref-type="fig"}).

Lineage tracings with *Mef2c-AHF^Cre^*, *Islet1^Cre^* and *Mesp1^Cre^* marked branchiomeric (temporal, masseter, digastric, mylohyoid and pharyngeal) and cucullaris-derived neck muscles (acromiotrapezius, spinotrapezius and sternocleidomastoid), all of which were excluded from the *Pax3* lineage ([Figure 1I--L](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2D--G'](#fig1s2){ref-type="fig"}). These findings support previous studies showing that cucullaris muscle development is controlled by a branchiomeric myogenic program ([@bib33]; [@bib40]; [@bib80]; [@bib88]). In addition, both *Mesp1* and *Pax3* lineages labeled somitic neck muscles ([Figure 1K--L'](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2F--G'](#fig1s2){ref-type="fig"}).

Analysis of different somite-derived neck muscles on sections showed that *Mesp1* and *Pax3* lineages gave rise to the great majority of the Pax7-positive myogenic population ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), demonstrating the high recombination efficiency obtained with the *Cre* lines. The results indicate that neck somitic muscles originate from myogenic cells that have expressed both *Mesp1* and *Pax3* genes.

To further investigate the contributions of *Mesp1* and *Pax3* lineages to neck muscles, we examined sections using the *R26^tdTomato^* reporter co-immunostained with the myofibre marker Tnnt3 at three representative levels (A, B and C levels in [Figure 1](#fig1){ref-type="fig"}; see also [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). At anterior levels, while *Pax3* lineage contribution was limited to somite-derived neck muscles, the *Mesp1* lineage marked branchiomeric muscles (mylohyoid, pharyngeal, laryngeal, esophagus), cucullaris-derived muscles (acromiotrapezius and sternocleidomastoid) and somite-derived neck muscles ([Figure 2A--H](#fig2){ref-type="fig"}, [Figure 1---figure supplement 2F--G'](#fig1s2){ref-type="fig"}, [Figure 2---figure supplement 2A--H'](#fig2s2){ref-type="fig"}). The epaxial and hypaxial neck muscles showed equivalent Tomato expression in both *Mesp1^Cre^;R26^tdTomato^* and *Pax3^Cre^;R26^tdTomato^* mice. These observations further indicate that *Mesp1* and *Pax3* lineages contribute equivalently to neck muscles derived from anterior somites.

![Differential contributions of *Mesp1* and *Pax3* lineages to neck and shoulders.\
Immunostainings on coronal cryosections of E18.5 *Mesp1^Cre^;R26^tdTomato^* and *Pax3^Cre^;R26^tdTomato^* mice for the myofibre Tnnt3 and Tomato markers at levels indicated in [Figure 1](#fig1){ref-type="fig"}. Higher magnifications of selected areas in (**A--J**) are shown in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}; (n = 2 for each condition). See also the atlas of neck musculature in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**A--H**) *Mesp1^Cre^* labeled all neck muscles including branchiomeric (myh, esm, phm and ilm), cucullaris (stm, atp), somitic epaxial (epm) and hypaxial (tg, lcp, lcl, ifh) muscles. *Pax3^Cre^* marked somitic muscles. (**I--J**) At shoulder level, *Mesp1*-derived cells did not contribute to posterior somitic myofibres including scapular muscles (scp) compared to that observed in *Pax3^Cre^* embryos. ac, arytenoid cartilage; acp, scapular acromion process; atp, acromiotrapezius; cc, cricoid cartilage; epm, epaxial musculature; esm, esophagus striated muscle; hh, humeral head; ifh, infrahyoid muscles; ilm, intrinsic laryngeal muscles; lcl, longus colli; lcp, longus capitis; myh, mylohyoid; ob, occipital bone; oc, otic capsule; phm, pharyngeal muscles; stm, sternocleidomastoid; scp, scapular musculature; tc, thyroid cartilage; tg, tongue. Scale bars: in J for A-B 200 µm, for C-J 400 µm.](elife-40179-fig2){#fig2}

At the shoulder level, we observed less *Mesp1* contribution to more posterior somitic muscles ([Figure 2I--J](#fig2){ref-type="fig"}). In contrast to that observed at anterior levels, little or no Tomato expression was detected in myofibres of scapular muscles in *Mesp1^Cre^;R26^tdTomato^* mice ([Figure 2---figure supplement 2I--J'](#fig2s2){ref-type="fig"}). Therefore, *Mesp1* lineage contribution was restricted to epaxial and hypaxial neck muscles, in contrast to pectoral and trunk muscles that originate from the *Pax3* lineage ([Figures 1](#fig1){ref-type="fig"}--[2](#fig2){ref-type="fig"}) ([Table 1](#table1){ref-type="table"}). These observations lead us to propose that three distinct myogenic programs are involved in the formation of neck and pectoral musculature at the head-trunk interface. The branchiomeric and cucullaris-derived muscles depend on a common myogenic program involving *Mef2c-AHF*, *Islet1* and *Mesp1* lineages; the somitic neck muscles that originate from anterior somites derive from both *Mesp1* and *Pax3* lineages; the pectoral muscles derived from more posterior somites depend on the activation of *Pax3* only ([Table 1](#table1){ref-type="table"}).
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###### Contribution of *Mef2c-AHF*, *Islet1*, *Mesp1* and *Pax3* lineages to neck and pectoral musculature.

  -------------------------------------------------------------------------------------------------------------------------------
  *Mef2c/Islet1/Mesp1-*derived muscles   *Mesp1/Pax3-*derived muscles                *Pax3*- derived muscles
  -------------------------------------- ------------------------------------------- --------------------------------------------
  Mylohyoid\                             Epaxial neck muscles\                       Scapular muscles\
  Digastric muscles \                    (splenius, semispinalis,\                   (supraspinatus, Infraspinatus,\
  \                                      levator scapula,\                           subscapularis)\
  \                                      rhomboid occipitalis,\                      \
  Pharyngeal muscles\                    suboccipital and\                           Pectoralis\
  Intrinsic laryngeal muscles\           postvertebral muscles)\                     \
  Esophagus striated muscle \            \                                           Latissimus dorsi^†^\
  \                                      Hypaxial neck muscles\                      Cutaneous maximus^†^
  Sternocleidomastoid \                  (tongue muscles\*,\                         
  Acromiotrapezius \                     infrahyoid muscles,\                        
  Spinotrapezius \                       longus capitis, longus colli)               

  **Branchiomeric myogenic program**     **Anterior-most somite myogenic program**   **More posterior somite myogenic program**
  -------------------------------------------------------------------------------------------------------------------------------

\*Including intrinsic and extrinsic tongue muscles of somitic origin.

^†^Also derived from an *Islet1* lineage.

Dual neural crest and mesodermal origins of neck connective tissues {#s2-2}
-------------------------------------------------------------------

To define the cellular origin of neck muscle-associated connective tissue (MCT), we traced the contribution of different embryonic populations using *Mesp1^Cre^;R26^tdTomato^* and *Pax3^Cre^;R26^tdTomato^* mice as well as *Wnt1^Cre^* and *Prx1^Cre^* reporters that label NCC and postcranial LPM derivatives, respectively ([@bib4]; [@bib9]; [@bib12]). Both NCC and LPM populations were reported to contribute to trapezius MCT ([@bib12]; [@bib48]). Moreover, it was suggested that the postcranial LPM is a source for cucullaris-derived muscles ([@bib88]). A direct comparison of NCC and LPM derivatives allowed us to clarify the contribution of these two populations to cucullaris formation ([Figures 3](#fig3){ref-type="fig"}--[4](#fig4){ref-type="fig"}).

![Neural crest contribution to neck muscle-associated tissue.\
Immunostainings on coronal cryosections of E18.5 *Wnt1^Cre^;R26^tdTomato^* mice at levels indicated in [Figure 1](#fig1){ref-type="fig"}. Tnnt3/Tomato immunostainings are shown in (**A--D**) and immunostainings for Tuj1/Tomato on selected areas of (**A--D**) are shown with higher magnifications in (**A'--D'**). See associated [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}--[4](#fig3s4){ref-type="fig"}; (n = 2). (**A--A'**) Note high *Wnt1* contribution in the acromiotrapezius but not in epaxial muscles where *Wnt1*-derived cells marked neuronal cells. (**B--C'**) *Wnt1*-derived cells marked differentially the distinct muscles composing the sternocleidomastoid and laryngeal musculatures. (**D--D'**) At shoulder level, the *Wnt1* cells did not contribute to attachment of acromiotrapezius to scapula. ac, arytenoid cartilage; acp, scapular acromion process; atp, acromiotrapezius; cc, cricoid cartilage; clm, cleidomastoid; clo, cleido-occipitalis; ct, cricothyroid; epm, epaxial musculature; hh, humeral head; ifh, infrahyoid muscles; lca, lateral cricoarytenoid; MCT, muscle-associated connective tissue; pca, posterior cricoarytenoid; phm, pharyngeal muscles; scp, scapular musculature; std, sternomastoid; tam, thyroarytenoid muscle; tc, thyroid cartilage; vm, vocal muscle. Scale bars: in D' for A-D 400 µm for A'-D' 200 µm.](elife-40179-fig3){#fig3}

![*Prx1*-LPM lineage contribution to neck and pectoral girdle.\
See also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [2](#fig4s2){ref-type="fig"}. (**A--D**) X-gal stainings of *Prx1^Cre^;R26R* reporter mice at E9.5 (n = 3) (**A**) and E18.5 (n = 3) (**C--D**), and immunostaining for GFP and the Pax7/Myod/My32 myogenic markers in *Prx1^Cre^;R26^mTmG^* E12.5 embryo (n = 2) (**B**). Note *Prx1*-derived cells in postcranial LPM (A, black arrowheads) and *Prx1*-derived cells among, but not in, cucullaris myofibres (**B--D**). (**E--F''**) Immunostaining for β-gal, Tnnt3 and Tcf4 on coronal cryosections of E18.5 *Prx1^Cre^;R26R* mice (n = 2) showed β-gal^+^ cells constituting the pectoral girdle (E, level C in [Figure 1](#fig1){ref-type="fig"}) and in MCT fibroblasts (F-F'', white arrowheads), but not in trapezius myofibres. acp, scapular acromion process; atp, acromiotrapezius; ccl, cucullaris anlage; ccp, scapular coracoid process; cl, clavicle; epm, epaxial musculature; hh, humeral head; lb, forelimb bud; lbm, limb muscle anlagen; LPM, lateral plate mesoderm; ltd, latissimus dorsi; PA1-6, pharyngeal arches 1--6; S3, somite 3; scp, scapular muscles; stm, sternocleidomastoid; stp, spinotrapezius. Scale bars: in A for A, B 500 µm; in C for C-D 2000 µm, for E 500 µm; in F'' for F-F'' 20 µm.](elife-40179-fig4){#fig4}

We first investigated the distribution of neck muscles and NCCs using *Myf5^nlacZ^*^/+^, *Mef2c-AHF^Cre^;R26R*, *Pax3^Cre^;R26R* and *Wnt1^Cre^;R26R* embryos ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). At E10.5, the cucullaris anlage was positioned at the level of posterior pharyngeal arches where *Wnt1*-derived-positive cells were detectable ([Figure 1A--C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A'](#fig1s1){ref-type="fig"}, [Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}). Subsequently, the cucullaris progenitors expanded caudally from E11.5 to E13.5. The posterior limit of the cranial NCC domain also extended posteriorly; however, the *Wnt1*-labeled cells did not cover the posterior portion of cucullaris-derived muscles ([Figure 3---figure supplement 1C--H](#fig3s1){ref-type="fig"}). At E14.5, the acromiotrapezius and spinotrapezius attained their definitive position in *Myf5^nlacZ^*^/+^ and *Mef2c-AHF^Cre^;R26R* embryos ([Figure 3---figure supplement 1I--J](#fig3s1){ref-type="fig"}). *Wnt1*-derived cells were observed in the anterior acromiotrapezius muscle, but not in the spinotrapezius that was situated in a *Pax3*-derived domain ([Figure 3---figure supplement 1K--L](#fig3s1){ref-type="fig"}). Analysis of whole-mount embryos indicated that the cranial NCCs did not contribute to connective tissue of posterior cucullaris derivatives, in contrast to what was reported previously ([@bib48]).

To further analyze NCC contribution to the cervical region at the cellular level, we performed immunostainings on sections for Tomato and Tnnt3 in E18.5 *Wnt1^Cre^;R26^tdTomato^* fetuses ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Given that the *Wnt1* lineage is a source of both neuronal and connective tissue derivatives, we associated Tomato immunostaining with Tuj1 that marks neuronal cells and with Tcf4 that labels MCT fibroblasts ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplements 2](#fig3s2){ref-type="fig"}--[3](#fig3s3){ref-type="fig"}). At the cranial level, the MCT of branchiomeric (masseter, mylohyoid), tongue and acromiotrapezius muscles was derived from *Wnt1*- and *Pax3-*lineages but not from the mesodermal *Mesp1* lineage ([Figure 3---figure supplement 2A--B'](#fig3s2){ref-type="fig"}, [Figure 3---figure supplement 3A,F](#fig3s3){ref-type="fig"}, [Figure 3---figure supplement 4A--D,G](#fig3s4){ref-type="fig"}). The acromiotrapezius showed a high contribution from *Wnt1*-derived cells while the underlying epaxial muscles had considerably less labeled cells that were limited to the neuronal Tuj1-positive population ([Figure 3A--A'](#fig3){ref-type="fig"}). The *Wnt1* lineage gave rise to Tcf4-positive fibroblasts in the acromiotrapezius, but not in epaxial neck muscles, where fibroblasts were derived from the *Mesp1* lineage ([Figure 3---figure supplements 3B--C](#fig3s3){ref-type="fig"} and [4E](#fig3s4){ref-type="fig"}). These observations are in accordance with a NCC origin of branchiomeric, anterior trapezius and tongue connective tissue as reported previously ([@bib48]).

However, the NCC contribution to connective tissue in the sternocleidomastoid subset of cucullaris-derived muscles appeared more heterogeneous than that observed in the acromiotrapezius. In rodents, the sternocleidomastoid is composed of three individual muscles (cleidomastoid, sternomastoid and cleido-occipitalis portions); a differential NCC contribution to MCT was observed in these muscles. While *Wnt1*-derived NCCs were widely present in the sternomastoid and cleido-occipitalis, the NCC contribution was limited in the cleidomastoid ([Figure 3B--B'](#fig3){ref-type="fig"}). Indeed, Tcf4-positive fibroblasts in the cleido-occipitalis originated from the *Wnt1* lineage, whereas the majority of MCT fibroblasts in the cleidomastoid were derived from the *Mesp1* lineage ([Figure 3---figure supplements 3D--E](#fig3s3){ref-type="fig"} and [4F](#fig3s4){ref-type="fig"}).

A differential contribution of NCCs to connective tissue was also seen within the laryngeal and infrahyoid musculature. Extensive *Wnt1* lineage contributions to MCT was observed in laryngeal muscles (thyroarytenoid and cricothyroid) that connect to the thyroid cartilage, which is of NCC origin ([Figure 3C--C'](#fig3){ref-type="fig"}) ([@bib83]). In contrast, the laryngeal muscles (cricoarytenoid and vocal muscles) that link mesoderm-derived laryngeal cartilages (cricoid, arytenoid and medio-caudal portion of the thyroid) did not contain NCC-derived connective tissue ([Figures 2G--H](#fig2){ref-type="fig"} and [3C--C'](#fig3){ref-type="fig"}) ([@bib83]). In these muscles, the *Wnt1*-derived cells were neuronal, as observed in the esophagus, whereas the MCT fibroblasts were derived from the *Mesp1* lineage ([Figure 3C--C'](#fig3){ref-type="fig"}, [Figure 3---figure supplements 2D--D'](#fig3s2){ref-type="fig"} and [4H](#fig3s4){ref-type="fig"}). As another example, *Wnt1*-derived cells contributed to a greater extent to MCT in infrahyoid muscles (thyrohyoid muscles) that connect the hyoid and thyroid cartilage that are of NCC origin, compared to infrahyoid muscles (omohyoid and sternohyoid muscles) that link posteriorly pectoral structures of mesodermal origin ([Figure 3---figure supplement 2C,C', H](#fig3s2){ref-type="fig"}; [Figure 3---figure supplement 3G--H](#fig3s3){ref-type="fig"}). These observations suggest that MCT composition within laryngeal and infrahyoid muscles correlates in part with the embryonic origin of the skeletal components to which they attach ([Figure 2G--H](#fig2){ref-type="fig"}, [Figure 3C--C'](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2C--C', H](#fig3s2){ref-type="fig"}).

Given our findings that connective tissues of neck muscles have differential contributions of NCC and mesodermal populations, we analyzed the caudal connections of the cucullaris-derived muscles to the pectoral girdle ([Figure 3D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2E--H](#fig3s2){ref-type="fig"}). The acromiotrapezius attaches dorsally to the nuchal ligament and ventrally to the scapular acromion process in continuity with the scapular spine. While *Wnt1-*derived cells were present dorsally ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2E](#fig3s2){ref-type="fig"}), this contribution diminished gradually and was undetectable at the insertion on the scapula ([Figure 3D--D'](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2F](#fig3s2){ref-type="fig"}). Similarly, the sternocleidomastoid muscle showed limited NCC contribution to the attachment sites of the clavicle and sternum ([Figure 3---figure supplement 2G--H](#fig3s2){ref-type="fig"}). In contrast to what was previously described ([@bib48]), we did not observe NCC contribution to the shoulder endochondral tissue nor to the nuchal ligament ([Figure 3---figure supplement 2E--H](#fig3s2){ref-type="fig"}). Taken together, these observations define a novel boundary for neural crest contribution to neck/pectoral components. The posterior contribution limit of neural crest to branchiomeric MCT occurs at the level of laryngeal muscles that connect to NCC skeletal derivatives. Moreover, NCCs do not participate in connecting posterior cucullaris and infrahyoid muscles to their skeletal elements.

To assess the cellular origin of cucullaris connective tissue at posterior attachment sites, we next traced the contribution of lateral plate mesoderm (LPM) to the neck/shoulder region using *Prx1^Cre^* reporter mice ([@bib12]; [@bib42]) ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[2](#fig4s2){ref-type="fig"}). Analysis of E9.5 embryos showed that *Prx1*-derived cells contribute to the forelimb bud and cells adjacent to the anterior-most somites, but not to pharyngeal arches ([Figure 4A](#fig4){ref-type="fig"}). At E12.5, the postcranial *Prx1*-derived domain clearly defined the lateral somitic frontier along the rostrocaudal axis ([@bib12]) and did not include the cucullaris anlage ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, white arrowheads). Whole-mount immunostainings for the myogenic markers Pax7/Myod/My32 and for GFP in *Prx1^Cre^;R26^mTmG^* embryos showed that *Prx1*-derived cells were present in the dorsal part of the cucullaris but did not contribute to myofibres ([Figure 4B](#fig4){ref-type="fig"}, white arrowheads). At E18.5, the *Prx1* lineage marked the limb, scapular and abdominal regions, whereas only a few *Prx1*-derived cells were detected in the cucullaris-derived sternocleidomastoid, acromiotrapezius and spinotrapezius muscles ([Figure 4C--D](#fig4){ref-type="fig"}). On sections, immunostaining for β-gal and Tnnt3 showed that *Prx1*-derived LPM contributed to limb/shoulder MCT and to skeletal components of the pectoral girdle ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2A--B](#fig4s2){ref-type="fig"}). In contrast, fewer *Prx1*-derived cells were detected in the acromiotrapezius and little or no contribution was observed in the epaxial muscles ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2B--C](#fig4s2){ref-type="fig"}). In addition, only a limited number of *Prx1*-derived cells gave rise to Tcf4-positive fibroblasts in the trapezius muscles, but they contributed more extensively to the fibroblast population in scapular muscles ([Figure 4F--F''](#fig4){ref-type="fig"}, white arrowheads, [Figure 4---figure supplement 2D--D"](#fig4s2){ref-type="fig"}). Notably, β-gal expression for this lineage was not detected in trapezius myofibres thereby confirming the results obtained at E12.5 ([Figure 4B--F"](#fig4){ref-type="fig"}, [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[2](#fig4s2){ref-type="fig"}).

Therefore, these observations reveal a dual NCC/LPM origin of trapezius connective tissue, with a decrease of NCC contribution at posterior attachment sites. Moreover, our analysis shows that the postcranial LPM does not give rise to cucullaris myofibres in contrast to what was suggested previously ([@bib88]), thus providing further evidence for a branchiomeric origin of the cucullaris.

Divergent functions of *Tbx1* and *Pax3* in neck development {#s2-3}
------------------------------------------------------------

Given the key role for *Tbx1* and *Pax3* genes in the specification of the CPM and somites respectively, we analyzed the effect of inactivation of these genes on neck muscle formation, compared to the muscle phenotypes observed at cranial and trunk levels.

Analysis has been performed by immunostainings on sections and 3D reconstructions of the neck and pectoral girdle using high-resolution micro-computed tomographic (µCT) scans of control, *Tbx1^-/-^* and *Pax3^-/-^* fetuses ([Figures 5](#fig5){ref-type="fig"}--[6](#fig6){ref-type="fig"}).

![Neck muscle phenotypes in *Tbx1* and *Pax3* mutants.\
(**A--I**) Immunostainings for Tnnt3 on coronal cryosections of control, *Tbx1-null* and *Pax3-null* fetuses at E18.5 (n = 3 each condition). Yellow asterisks indicate missing muscles. Note absence of branchiomeric laryngeal (ilm), esophagus (esm) and trapezius (atp) muscles and severe alteration of somitic infrahyoid muscles (ifh) in *Tbx1* mutants. Scapular (scp) and pectoral (ptm) muscles are missing in *Pax3* mutants. ac, arytenoid cartilage; atp, acromiotrapezius; cc, cricoid cartilage; cl, clavicle; epm, epaxial musculature; esm, esophagus striated muscle; ifh, infrahyoid muscles; ilm, intrinsic laryngeal muscles; lcp, longus capitis; ptm, pectoralis muscles; sc, scapula; scp, scapular muscles; st, sternum; tc, thyroid cartilage; tg, tongue. Scale bars: in A for A-I 500 µm.](elife-40179-fig5){#fig5}

![3D reconstructions of neck musculoskeletal system in *Tbx1* and *Pax3* mutants.\
See interactive 3D PDFs in [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[3](#supp3){ref-type="supplementary-material"}; control n = 1; mutants n = 2. (**A--C**) Branchiomeric and cucullaris-derived muscles marked by *Mef2c-AHF/Islet1/Mesp1* lineages are indicated in pink. (**D--F**) Anterior somitic muscles (*Mesp1, Pax3* lineages), in red. (**G--I**) Scapular muscles from more posterior somites (*Pax3* lineage), in violet. atp, acromiotrapezius; cc, cricoid cartilage; dg, digastric muscles; epm, epaxial musculature; ifh, infrahyoid muscles; ilm, intrinsic laryngeal muscles; lcl, longus colli; lcp, longus capitis; myh, mylohyoid; sc, scapula; scp, scapular muscles; stm, sternocleidomastoid; tc, thyroid cartilage; tg, tongue.](elife-40179-fig6){#fig6}

In the early embryo, *Tbx1* is expressed in pharyngeal mesoderm and is required for proper branchiomeric muscle formation ([@bib21]; [@bib33]). While *Tbx1* is expressed in other cranial populations including the pharyngeal ectoderm and endoderm ([@bib2]; [@bib29]), the gene is known to be required cell autonomously during CPM myogenesis ([@bib34]; [@bib95]). Analysis of *Tbx1* mutants revealed unexpected features in cucullaris and hypaxial neck muscle formation. As previously described ([@bib19]; [@bib33]), anterior branchiomeric muscles (digastric and mylohyoid) showed phenotypic variations, whereas posterior branchiomeric muscles (esophagus and intrinsic laryngeal muscles) and the acromiotrapezius were severely affected or undetectable ([Figure 5B,E,H](#fig5){ref-type="fig"}; [Figure 6B](#fig6){ref-type="fig"}) ([Table 2](#table2){ref-type="table"}). However, detailed examination of the cucullaris-derived muscles revealed a heterogeneous dependence on *Tbx1* function that was not reported previously ([@bib40]; [@bib88]). Unexpectedly, the sternocleidomastoid muscle was present bilaterally but smaller ([Figure 6B](#fig6){ref-type="fig"}); the different portions (cleido-occipitalis, cleidomastoid and sternomastoid) were unilaterally or bilaterally affected in a stochastic manner. Moreover, while the epaxial neck and scapular muscles were unaffected ([Figure 5E](#fig5){ref-type="fig"}, [Figure 6E--H](#fig6){ref-type="fig"}), the hypaxial neck muscles derived from anterior somites were altered. Indeed, the tongue and longus capitis were reduced and the infrahyoid and longus colli muscles were severely affected or undetectable ([Figure 5B,H](#fig5){ref-type="fig"}, [Figure 6E,H](#fig6){ref-type="fig"}; see interactive 3D PDFs in [Supplementary file 1](#supp1){ref-type="supplementary-material"}--[2](#supp2){ref-type="supplementary-material"}).

10.7554/eLife.40179.020

###### Summary of the neck muscle phenotype observed in *Tbx1-* and *Pax3-*null fetuses.

  ---------------------------------------------------------------------------------------------------
                                                                  ***Tbx1*-null**   ***Pax3*-null**
  --------------------------------------------------------------- ----------------- -----------------
  **Branchiomeric muscles (*Mef2c-AHF/Islet1/Mesp1* lineage)**\   \                 \
  Mylohyoid\                                                      +/-\              ++\
  Digastric muscles\                                              +/-\              ++\
  Intrinsic laryngeal muscles\                                    −\                +\
  Esophagus striated muscle\                                      −\                ++\
  Sternocleidomastoid\                                            +/-\              +\
  Acromiotrapezius                                                −                 +

  **Anterior-most somite muscles (*Mesp1/Pax3* lineage)**\        \                 \
  Epaxial musculature\                                            ++\               +\
  Longus capitis\                                                 +/-\              ++\
  Longus colli\                                                   −\                ++\
  Infrahyoid muscles\                                             −\                +/-\
  Tongue muscles\*                                                +                 +

  **More posterior somite muscles (*Pax3* lineage)**\             \                 \
  Scapular muscles\                                               ++\               −\
  Pectoralis                                                      ++                −
  ---------------------------------------------------------------------------------------------------

++,normal; +, altered morphology; +/-, affected; -, severely affected or undetectable.

\*Including intrinsic and extrinsic tongue muscles of somitic origin.

Analysis of *Pax3* mutants showed that the neck and pectoral muscles were differentially affected. As expected, branchiomeric and epaxial muscles developed normally but displayed morphological differences adapted to malformations noted in some skeletal components ([Figure 5C,F](#fig5){ref-type="fig"}; [Figure 6C,I](#fig6){ref-type="fig"}). However, whereas hypaxial trunk/limb muscles were severely affected or undetectable in *Pax3* mutants ([Figure 5F,I](#fig5){ref-type="fig"}; [Figure 6F,I](#fig6){ref-type="fig"}) ([@bib86]; [@bib89]), surprisingly the majority of hypaxial neck muscles derived from both *Mesp1* and *Pax3* lineages were present. Tongue muscles were reduced in size but patterned, the infrahyoid were hypoplastic, whereas the longus capitis and longus colli were unaffected ([Figure 5C](#fig5){ref-type="fig"}; [Figure 6F,I](#fig6){ref-type="fig"}; see interactive 3D PDF in [Supplementary file 3](#supp3){ref-type="supplementary-material"}). The phenotypes of the different muscle groups observed in *Tbx1* and *Pax3* mutants are summarized in [Table 2](#table2){ref-type="table"} (see also [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).

Taken together, these observations revealed that hypaxial muscles in the neck were less affected in *Pax3* mutants than more posterior hypaxial muscles, pointing to distinct requirements for *Pax3* function during neck and trunk muscle formation. In addition, *Tbx1* mutants exhibited more severe phenotypes in hypaxial neck muscles, thus highlighting distinct roles for this gene in branchiomeric and hypaxial neck myogenesis.

Discussion {#s3}
==========

The embryological origins of neck muscles and connective tissues at the head-trunk interface have been poorly defined largely due to their localization at a transition zone that involves multiple embryonic populations. Using a combination of complementary genetically modified mice and 3D analysis that identifies muscles in the context of their bone attachments, we provide a detailed map of neck tissue morphogenesis and reveal some unexpected features regarding the muscle and connective tissue network.

Branchiomeric origin of cucullaris-derived muscles {#s3-1}
--------------------------------------------------

The mammalian neck consists of somitic epaxial/hypaxial muscles, branchiomeric muscles and cucullaris-derived muscles ([Table 1](#table1){ref-type="table"}). The latter constitute a major innovation in vertebrate history, connecting the head to the pectoral girdle in gnathostomes and allowing head mobility in tetrapods ([@bib17]). Recent studies in different organisms including shark, lungfish and amphibians suggest that the cucullaris develops in series with posterior branchial muscles and that its developmental origin and innervation is conserved among gnathostomes ([@bib10]; [@bib17]; [@bib55]; [@bib56]; [@bib80]; [@bib84]; [@bib97]; [@bib96]). However, multiple embryological origins including CPM, LPM and somites have been reported for the cucullaris, underscoring the difficulty in deciphering the morphogenesis of this and other muscles in the head-trunk transition zone ([@bib28]; [@bib52]; [@bib80]; [@bib88]).

Our study shows that the cucullaris anlage is innervated by the accessory nerve XI and develops contiguously with the mesodermal core of posterior arches and anterior-most somites 1--3. Our lineage analysis reveals that cucullaris development depends on a branchiomeric myogenic program involving *Mef2c-AHF*, *Islet1* and *Mesp1* lineages in keeping with previous results ([Table 1](#table1){ref-type="table"}) ([@bib40]; [@bib80]; [@bib88]). However, our detailed functional analysis and 3D reconstructions lead us to modify the view of the genetic requirements of cucullaris-derived muscles ([@bib40]; [@bib88]). Notably, these muscles are differentially affected in *Tbx1*-null fetuses; the acromiotrapezius does not form while the sternocleidomastoid is present but reduced. Therefore, *Tbx1* is differentially required for sternocleidomastoid and trapezius formation, suggesting that distinct subprograms regulate cucullaris development.

We also demonstrate that the cucullaris anlage is excluded from the postcranial *Prx1*-derived expression domain, which delineates the trunk LPM field ([Figure 4](#fig4){ref-type="fig"}). The *Prx1* lineage instead gives rise to connective tissue, thereby excluding a contribution from LPM to cucullaris-derived myofibres. Thus, our results, combined with innervation studies, retrospective clonal analyses and grafting experiments in chick and axolotl ([@bib40]; [@bib52]; [@bib80]; [@bib84]), suggest that the postcranial extension of the CPM lateral to the first three somites in tetrapod embryos is a source of cucullaris myogenic cells ([Figure 7A](#fig7){ref-type="fig"}). The discordance with previous studies regarding the origin of the cucullaris is likely due to its proximity to both anterior somites and LPM ([Figure 7A--B](#fig7){ref-type="fig"}), and consequently, to potential contamination of embryonic sources in grafting experiments ([@bib8]; [@bib27]; [@bib28]; [@bib57]; [@bib66]; [@bib88]).

![Model for musculoskeletal and connective tissue relationships during murine neck development.\
See also [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. (**A, C**) CPM (pink), anterior somites (red) and more posterior somites (violet) muscles are defined by three distinct myogenic programs. (**B**) Note that the cucullaris develops in a NC domain (blue dots), but is excluded from the postcranial LPM (yellow dots). (**C**) Dual NC/LPM origin of trapezius connective tissue is indicated in (**a**). NC contribution to connective tissue extends to tongue and anterior infrahyoid musculature (**b**). (**D**) Mixed origins of muscle connective tissues at the head-trunk-limb interface. Example of representative muscles: (**a**) masseter, (**b**) spinalis dorsi, (**c**) deltoid. atp, acromiotrapezius; ccl, cucullaris; CPM, cardiopharyngeal mesoderm; epm, epaxial neck musculature; hpm, hypaxial neck musculature; hy, hyoid bone; LPM, postcranial lateral plate mesoderm; NC, neural crest; PA1-2, pharyngeal arches 1--2; PM, paraxial mesoderm; stm, sternocleidomastoid; stp, spinotrapezius; tc, thyroid cartilage.](elife-40179-fig7){#fig7}

A unique genetic program for somite-derived neck muscles {#s3-2}
--------------------------------------------------------

Our study also points to a unique *Mesp1*/*Pax3* genetic program in anterior somites for epaxial/hypaxial neck muscle formation ([Table 1](#table1){ref-type="table"}). While it was shown that the *Mesp1* lineage gives rise to tongue muscles ([@bib26]), we demonstrate that it also contributes to all neck muscles. In chordates, *Mesp* genes appear to play a conserved role in cardiogenesis and axis segmentation. In mouse, *Mesp1* inactivation causes early embryonic death from abnormal heart development, and *Mesp1/Mesp2* double-knockout embryos lack non-axial mesoderm ([@bib50]; [@bib73]; [@bib75]; [@bib78]; [@bib79]). During early murine development, *Mesp1* shows two waves of activation; initially in the nascent mesoderm destined for extraembryonic, cranial and cardiac mesoderm at the onset of gastrulation; later during somitogenesis, transient *Mesp1* expression is limited to anterior presomitic mesoderm ([@bib73]; [@bib72]; [@bib75]; [@bib74]). Our lineage analysis shows that *Mesp1* extensively labels the anterior mesoderm, including the CPM and anterior somites 1--6, while contribution decreases in more posterior somites ([Figure 1](#fig1){ref-type="fig"}) ([@bib41]; [@bib75]; [@bib74]). Previous fate mapping experiments have shown that the mesoderm of late-streak stage embryos contributes to both CPM and anterior somites ([@bib63]). It appears that the first wave of *Mesp1* expression defines not only the CPM field but also includes the mesoderm destined for anterior somites. In contrast, the *Mesp1*-labeled cells observed in more posterior somites using the sensitive *Pax7^GPL^* reporter may result from the transient wave of *Mesp1* expression in the presomitic mesoderm during axis segmentation. Furthermore, we show that *Mesp1*-derived anterior somites give rise to all epaxial/hypaxial neck muscles in contrast to trunk/limb muscles originating from more posterior somites marked by *Pax3*. The boundary of *Mesp1* lineage contribution to muscles corresponds to the neck/pectoral interface. Our findings indicate that the anterior somitic mesoderm employs a specific transition program for neck muscle formation involving both *Mesp1* and *Pax3* genes implicated in CPM and somitic myogenesis, respectively ([Figure 7A--C](#fig7){ref-type="fig"}).

Whereas little is known about the function of *Mesp* genes in chordates, there is evidence that *Mesp1* might be differentially required during anterior *versus* posterior somitic formation. In mouse, different *Mesp1* enhancer activities have been observed between CPM/anterior somites and posterior somites indicating that the regulation of *Mesp1* expression might differ in the two embryonic compartments ([@bib25]). In zebrafish, quadruple mutants of *Mesp* genes (*Mesp-aa/-ab/-ba/-bb*) lack anterior somite segmentation while the positioning of posterior somite boundaries is unaffected, suggesting distinct requirements for *Mesp* genes in anterior and posterior somites ([@bib92]). Interestingly, during early ascidian development, *Mesp* is expressed in B7.5 founder cells that give rise to both CPM and anterior tail muscles (ATM) ([@bib78]). In *Ciona*, the CPM precursors at the origin of heart and atrial siphon (pharyngeal) muscles depend on the ascidian homologs of *Mesp1*, *Islet1* and *Tbx1* (reviewed in \[[@bib11]\]), indicating that a conserved genetic network promotes chordate myogenesis in the anterior embryonic domain.

Our lineage analysis also reveals an unexpected contribution of *Islet1*-derived cells to the formation of cutaneous maximus and latissimus dorsi muscle progenitors ([Table 1](#table1){ref-type="table"}) ([@bib68]; [@bib89]). *Islet1* is activated in a subset of CPM progenitors giving rise to branchiomeric muscles and second heart field myocardium ([@bib5]; [@bib26]; [@bib54]). At the trunk level, while *Islet1* is widely expressed in the nervous system and in the LPM forming the hindlimb bud ([@bib5]; [@bib93]), to our knowledge its expression in somitic myogenic cells has not been reported. The cutaneous maximus and latissimus dorsi muscles are missing in both *Pax3* and *Met* mutants ([@bib68]; [@bib86]; [@bib89]). Therefore, the formation of the latissimus dorsi and cutaneous maximus muscles depends on a specific developmental program implicating *Pax3*, *Islet1* and *Met* genes. Given that the latissimus dorsi and cutaneous maximus participated in the gain in mobility of the forelimbs towards the shoulder girdle in tetrapods, our findings provide insights into their genetic and evolutionary origins.

Our detailed analysis of *Tbx1-* and *Pax3-*null mice on sections and in 3D reconstructions now provides a clarified view of neck muscle morphogenesis ([Table 2](#table2){ref-type="table"}). In both *Tbx1* and *Pax3* mutants, whereas the epaxial neck musculature is unaffected, the hypaxial muscles originating from anterior somites are perturbed with a more severe phenotype observed in *Tbx1* mutants ([Table 2](#table2){ref-type="table"}). Whereas no *Tbx1* expression has been reported in early myotomes in somites, *Tbx1* transcripts appear in hypaxial limb and tongue precursors after myogenic specification ([@bib21]; [@bib33]; [@bib99]). *Tbx1*-null embryos show normal myotomal and limb muscle morphology while the hypoglossal cord is hypoplastic, resulting in reduced tongue musculature ([Table 2](#table2){ref-type="table"}) ([@bib21]; [@bib33]). Therefore, we cannot exclude the possibility that *Tbx1* is activated and plays a role after specification of neck hypaxial muscles ([@bib60]; [@bib99]). The hypaxial muscle defects might also be secondary to a failure of caudal pharyngeal outgrowth ([@bib33]). While *Tbx1* acts cell autonomously in mesodermal progenitors ([@bib34]; [@bib95]), its expression in pharyngeal endoderm might imply an indirect role in CPM myogenesis ([@bib2]). Defects in signaling from pharyngeal endoderm may explain the hypoglossal cord deficiency and the potential non-autonomous role for *Tbx1* in neck hypaxial myogenesis. Detailed analysis of muscle formation in conditional *Tbx1* mutants is needed to resolve the relative roles of *Tbx1* in neck myogenesis.

It has been shown that hypaxial muscles are perturbed to a greater extent than epaxial muscles in *Pax3* mutants ([@bib86]; [@bib89]), suggesting a different requirement for *Pax3* in these muscle groups, possibly through differential gene regulation ([@bib3]). An unexpected outcome of our analysis was that hypaxial neck muscles (derived from *Mesp1* and *Pax3* lineages) are less perturbed in *Pax3*-null mutants than hypaxial trunk/limb muscles (*Pax3* lineage only) that are severely altered or undetectable ([Table 2](#table2){ref-type="table"}). Our results indicate that *Pax3* is not essential for the formation of neck muscles derived from anterior somites in contrast to hypaxial muscles originating from more posterior somites. These observations support our model that a distinct genetic program governs somitic neck muscles compared to more posterior trunk muscles.

Connectivity network of the neck and shoulders {#s3-3}
----------------------------------------------

Assessing the non-muscle contribution to the neck region is a major challenge due to the extensive participation of diverse cell types from different embryological origins. Previous studies in amphibians, chick and mouse reported that branchiomeric and hypobranchial connective tissue originates from NCCs ([@bib24]; [@bib35]; [@bib48]; [@bib57]; [@bib61]; [@bib98]). It has been shown that the neural crest provides connective tissue for muscles that link the head and shoulders, whereas mesodermal cells give rise to connective tissue for muscles connecting the trunk and limbs ([@bib48]).

Our findings demonstrate that not all branchiomeric muscles are composed of neural crest-derived connective tissue, thereby redefining a new limit for NCC contribution to the neck and shoulders. Unexpectedly, we noted that the contribution of the neural crest lineage is limited in infrahyoid and posterior branchiomeric muscles that connect skeletal components of mesodermal origin. Indeed, it appears that the connective tissue of muscles that link exclusively mesodermal skeletal derivatives is of mesodermal origin. In contrast, the connective tissue of cucullaris-derived muscles is of a mixed origin, first developing in a cranial NCC domain at early stages, then expanding to incorporate connective tissue from both neural crest and LPM populations ([Figure 7B](#fig7){ref-type="fig"}). While NCCs are present in the anterior acromiotrapezius, sternocleidomastoid and infrahyoid muscles, contribution gradually decreases at posterior attachment sites and is undetectable at scapular level. In parallel, the LPM gives rise to shoulder skeletal components and to connective tissue at the attachment sites of associated musculature including trapezius muscles ([Figure 7C](#fig7){ref-type="fig"}). Therefore, the dual NCC/LPM origin of the trapezius connective tissue correlates with the embryonic origin of skeletal components to which it is connected.

*Wnt1^Cre^* and *Sox10^Cre^* NCC reporter mice were used to show that endochondral cells connecting the cucullaris-derived muscles on the scapula, clavicle and sternum share a common NCC origin with the connective tissue ([@bib48]). However, NCCs are not found in pectoral components of fish, axolotl and chick, while contribution to neurocranium is conserved, suggesting that NCC involvement in shoulder formation would be specific to mammals ([@bib16]; [@bib31]; [@bib65]; [@bib67]). In contrast to this view, our lineage analysis reveals that the neural crest lineage shows limited contribution to cucullaris connective tissue and does not form endochondral cells at the posterior attachment sites ([Figure 7C](#fig7){ref-type="fig"}). Differences in genetic lineage tracers and reagents might explain these discordant results ([@bib48]).

Taken together, our findings indicate that the gradient of neural crest and mesodermal contributions to neck connective tissue depends on the embryonic source of attachment sites. Therefore, it reveals that connective tissue composition in the neck region correlates with the cellular origin of associated skeletal components, independently of the myogenic source or ossification mode, forming a strong link between muscles and bones of the head, trunk and limb fields ([Figure 7D](#fig7){ref-type="fig"}).

Evolutionary and clinical perspectives {#s3-4}
--------------------------------------

Our findings demonstrate that the hybrid origin of the skeletal, connective tissue and muscle components of the neck is defined during early embryogenesis. The close proximity of neural crest, CPM, LPM and somitic populations is unique along the body plan and underscores the difficulty in defining their relative contributions to structures in the neck ([Figure 7A--B](#fig7){ref-type="fig"}). Our results refine the relative contributions of the neural crest and mesodermal derivatives in mouse, thereby providing a coherent view of embryonic components at the head-trunk interface in gnathostomes. Our study highlights the limited NCC contribution to posterior branchiomeric and infrahyoid muscle connective tissue, that is instead of mesodermal origin. This reinforces recent notions suggesting that the cranial NCCs and the postcranial rearrangement of mesodermal populations at the head-trunk interface had been central for the establishment of the neck during gnathostome evolution ([@bib1]; [@bib37]; [@bib43]; [@bib52]; [@bib80]). The contribution of anterior mesoderm in the origin of the neck needs to be elucidated in future studies of gnathostomes.

Our study reveals that neck muscles develop in a complex domain that is distinct from the head and trunk ([Figure 7A--D](#fig7){ref-type="fig"}), and that might be a contributing factor to pathologies that affect subsets of neck muscles in specific myopathies ([@bib14]; [@bib69]). In human, *TBX1* has been identified as a major candidate gene for 22q11.2 deletion syndrome ([@bib62]). Laryngeal malformations, esophageal dysmotility and shortened neck are frequent in patients. Moreover, the neck deficiencies might not be exclusively due to cervical spine abnormalities but also to neck muscle defects ([@bib23]; [@bib38]; [@bib46]). Therefore, our analysis of *Tbx1-*null mutants provides a better understanding of the etiology of the 22q11.2 deletion syndrome and has direct implications in establishing clinical diagnosis in cases where patients present failure in neck-associated functions.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation           Source or reference        Identifiers          Additional information
  (species) or resource                                                                         
  ----------------------- --------------------- -------------------------- -------------------- ----------------------------------
  Strain, strain\         B6D2F1/JRj            Janvier                                         
  background\                                                                                   
  (*Mus musculus*)                                                                              

  Genetic\                *Mef2c-AHF^Cre^*      PMID:16188249              MGI:3639735          Dr. Brian L Black\
  reagent\                                                                                      (Cardiovascular Research\
  (*M. musculus*)                                                                               Institute, University of\
                                                                                                California, USA)

  Genetic\                *Islet1^Cre^*         PMID:11299042              MGI:2447758          Dr. Thomas M Jessell\
  reagent\                                                                                      (Howard Hughes Medical\
  (*M. musculus*)                                                                               Institute, Columbia\
                                                                                                University, USA)

  Genetic\                *Mesp1^Cre^*          PMID:10393122              MGI:2176467          Pr. Yumiko Saga\
  reagent\                                                                                      (National Institute of\
  (*M. musculus*)                                                                               Genetics, Japan)

  Genetic\                *Pax3^Cre^*           PMID:22394517              MGI:3573783          Dr. Jonathan A. Epstein\
  reagent\                                                                                      (Perelman Shool of Medicine,\
  (*M. musculus*)                                                                               University of Pennsylvania, USA)

  Genetic\                *Myf5^Cre^*           PMID:17418413              MGI:3710099          Dr. Mario R Capecchi\
  reagent\                                                                                      (Institute of Human\
  (*M. musculus*)                                                                               Genetics, University\
                                                                                                of Utah, USA)

  Genetic\                *Wnt1^Cre^*           PMID:9843687               MGI:J:69326          Pr. Andrew P. McMahon\
  reagent\                                                                                      (Keck School of Medicine\
  (*M. musculus*)                                                                               of the University of\
                                                                                                Southern California, USA)

  Genetic\                *Prx1^Cre^*           PMID:12112875              MGI: J:77872         Dr. Clifford J Tabin\
  reagent\                                                                                      (Department of genetics,\
  (*M. musculus*)                                                                               Harvard Medical School, USA)

  Genetic\                *Pax7^GPL^*           PMID:19531352              MGI:3850147          Dr. Shahragim Tajbakhsh\
  reagent\                                                                                      (Department of Developmental\
  (*M. musculus*)                                                                               and Stem Cell Biology,\
                                                                                                Institut Pasteur, France)

  Genetic\                *Rosa26^R-lacZ^*      PMID:9916792               MGI:1861932          Pr. Philippe Soriano\
  reagent\                                                                                      (Icahn School of Medicine\
  (*M. musculus*)                                                                               at Mt. Sinai, USA)

  Genetic\                *R26^mTmG^*           PMID:17868096              MGI:3716464          Pr. Philippe Soriano\
  reagent\                                                                                      (Icahn School of Medicine\
  (*M. musculus*)                                                                               at Mt. Sinai, USA)

  Genetic\                *R26^tdTomato^*       PMID:20023653              MGI:3809524          Dr. Hongkui Zeng\
  reagent\                                                                                      (Allen Institute for Brain\
  (*M. musculus*)                                                                               Science, USA)

  Genetic\                *Myf5^nlacZ/+^*       PMID:8918877               MGI:1857973          Dr. Shahragim Tajbakhsh\
  reagent\                                                                                      (Department of Developmental\
  (*M. musculus*)                                                                               and Stem Cell Biology,\
                                                                                                Institut Pasteur, France)

  Genetic\                *Tbx1-null*           PMID:11242110              MGI:2179190          Dr. Virginia Papaioannou\
  reagent\                                                                                      (Department of Genetics\
  (*M. musculus*)                                                                               and Development,\
                                                                                                Columbia University\
                                                                                                Medical Center, USA)

  Antibody                Chicken polyclonal\   Abcam                      Cat. \#: ab9361      IF (1:1000)
                          anti-β-gal                                                            

  Antibody                Rabbit polyclonal\    MP Biomedicals             Cat. \#: MP 559761   IF (1:750)
                          anti-β-gal                                                            

  Antibody                Chicken polyclonal\   Aves Labs                  Cat. \#: 1020        IF (1:500)
                          anti-GFP                                                              

  Antibody                Chicken polyclonal\   Abcam                      Cat. \#: 13970       IF (1:1000)
                          anti-GFP                                                              

  Antibody                Mouse monoclonal\     DSHB                       Cat. \#: 40.2D6      IF (1:1000)
                          IgG1 anti-Islet1                                                      

  Antibody                Mouse monoclonal\     Sigma                      Cat. \#: M4276       IF (1:400)
                          IgG1 anti-My32                                                        

  Antibody                Mouse monoclonal\     Dako                       Cat. \#: M3512       IF (1:100)
                          IgG1 anti-Myod                                                        

  Antibody                Mouse monoclonal\     DSHB                       Cat. \#: AB_528428   IF (1:20)
                          IgG1 anti-Pax7                                                        

  Antibody                Rabbit polyclonal\    Cell Signalling            Cat. \#: C48H11      IF (1:150)
                          anti-Tcf4                                                             

  Antibody                Mouse monoclonal\     Sigma                      Cat. \#: T6277       IF (1:200)
                          IgG1 anti-Tnnt3                                                       

  Antibody                Rabbit polyclonal\    Clontech                   Cat. \#: 632496      IF (1:500)
                          anti-Tomato                                                           

  Antibody                Mouse monoclonal\     Ozyme                      Cat. \#: BLE801202   IF (1:1000)
                          IgG2a anti-Pax7                                                       

  Software,\              GE phoenix\           GE Sensing and\                                 
  algorithm               datos\|x 2.0          Inspection Technologies\                        
                                                GmbH                                            

  Software,\              3D PDF maker          SolidWorks\                                     
  algorithm                                     Corporation                                     

  Software,\              Zen                   Zeiss                                           
  algorithm                                                                                     

  Chemical\               X-gal                 Fisher                     Cat. \#: 10554973    
  compound, drug                                                                                

  Chemical\               paraformaldehyde      Electron Microscopy\       Cat. \#: 15710       
  compound, drug                                Sciences                                        

  Chemical\               Triton X-100          Sigma                      Cat. \#: T8787       
  compound, drug                                                                                

  Chemical\               Tween 20              Sigma                      Cat. \#: P1379       
  compound, drug                                                                                

  Chemical\               Histoclear II         National Diagnostics       Cat. \#: HS-202      
  compound, drug                                                                                
  --------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

Animals were handled as per European Community guidelines and the ethics committee of the Institut Pasteur (CTEA) approved protocols (APAFIS\#6354--20160809 l2028839). Males carrying the *Cre* driver gene, *Mef2c-AHF^Cre^* ([@bib91]), *Islet1^Cre^* ([@bib82]), *Mesp1^Cre^* ([@bib74]), *Pax3^Cre^* ([@bib15]), *Myf5^Cre^* ([@bib22]), *Wnt1^Cre^* ([@bib9]), *Prx1^Cre^* ([@bib42]), were crossed to reporter females from previously described lines including *Pax7^GPL^* ([@bib77]), *Rosa26^R-lacZ^* (*R26R*) ([@bib81]), *R26^mTmG^* ([@bib51]) and *R26^tdTomato^* ([@bib45]). *Myf5^nlacZ/+^* KI mice and mice carrying the *Tbx1^tm1pa^* allele (referred to as *Tbx1-*null) were previously described ([@bib30]; [@bib33]; [@bib85]). To generate experimental *Pax3-*null fetuses, *Pax3^WT/Cre^* males and females were intercrossed ([@bib15]) (n = 5 *Tbx1* and *Pax3* mutants analysed including n = 2 by µCT scanning). Mice were crossed and maintained on a B6D2F1/JRj background and genotyped by PCR. Mouse embryos and fetuses were collected between E9.5 and E18.5, with noon on the day of the vaginal plug considered as E0.5.

X-gal and immunofluorescence stainings {#s4-2}
--------------------------------------

Whole-mount samples were analysed for beta-galactosidase activity with X-gal (0.6 mg/ml) in 1X PBS buffer (D1408, Sigma, St. Louis, MO) containing 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, 0.02% NP-40 and 2 mM MgCl~2~ as previously described ([@bib6]). For immunostaining on cryosections, foetuses were fixed 3 hr in 4% paraformaldehyde (PFA) (15710, Electron Microscopy Sciences, Hatfield, PA) 0.5% Triton X-100 (T8787, Sigma) at 4°C, washed overnight at 4°C in PBS 0.1% Tween 20 (P1379, Sigma), cryopreserved in 30% sucrose in PBS and embedded in OCT for 12--16 µm sectioning with a Leica cryostat (CM3050 S, Leica, Wetzlar, Germany). Cryosections were dried for 30 min and washed in PBS. For immunostaining on paraffin sections, samples were fixed overnight in 4% PFA, dehydrated in graded ethanol series and penetrated with Histoclear II (HS-202, National Diagnostics, Atlanta, GA), embedded in paraffin and oriented in blocks. Paraffin blocks were sectioned at 10--12 µm using a Leica microtome (Reichert-Jung 2035). Sections were then deparaffinized and rehydrated by successive immersions in Histoclear, ethanol and PBS. Samples were then subjected to antigen retrieval with 10 mM Citrate buffer (pH 6.0) using a 2100 Retriever (Aptum Biologics, Rownhams, UK).

Rehydrated sections were blocked for 1 hr in 10% normal goat serum, 3% BSA, 0.5% Triton X-100 in PBS. Primary antibodies were diluted in blocking solution and incubated overnight at 4°C. Primary antibodies included the following: β-gal (1/1000, chicken polyclonal, ab9361, Abcam, Cambridge, UK; 1/750, rabbit polyclonal, MP 559761, MP Biomedicals, Illkirch, France), GFP (1/500, chick polyclonal, 1020, Aves Labs, Tigard, OR; 1/1000, chick polyclonal, 13970, Abcam), Islet1 (1/1000, mouse monoclonal IgG1, 40.2D6, DSHB), My32 (1/400, mouse monoclonal IgG1, M4276, Sigma), Myod (1/100, mouse monoclonal IgG1, M3512, Dako, Santa Clara, CA), Pax7 (1/20, mouse monoclonal IgG1, AB_528428), Tcf4 (1/150, rabbit polyclonal, C48H11, Cell Signalling, Leiden, Netherlands), Tnnt3 (1/200, monoclonal mouse IgG1, T6277, Sigma), Tomato (1/500, rabbit polyclonal, 632496, Clontech, Shiga, Japan; 1/250, chick polyclonal, 600-901-379, Rockland, Pottstown, PA) and Tuj1 (1/1000, monoclonal mouse IgG2a, BLE801202, Ozyme, Montigny-le-Bretonneux, France). After 3 rounds of 15 min washes in PBS 0.1% Tween 20, secondary antibodies were incubated in blocking solution 2 hr at RT together with 1 μg/ml Hoechst 33342 to visualize nuclei. Secondary antibodies consisted of Alexa 488, 555 or 633 goat anti-rabbit, anti-chicken or anti-mouse isotype specific (1/500, Jackson Immunoresearch, Cambridgeshire, UK). After 3 rounds of 15 min washes in PBS 0.1% Tween 20, slides were mounted in 70% glycerol for analysis.

For whole-mount immunofluorescence staining, embryos were dissected in PBS, fixed in 4% PFA, washed in PBS and stored at −20°C in 100% methanol. After rehydration in PBS, whole mount immunostainings were performed incubating the primary and secondary antibodies for 3 days each. Samples were cleared using benzyl alcohol/benzyl benzoate (BABB) clarification method ([@bib94]).

µCT scan analysis {#s4-3}
-----------------

For µCT scan analysis, the fetuses were treated with the phosphotungstic acid (PTA) contrast agent to well reveal skeletal and muscle structures. After dissection of the cervical region (including the mandible and scapular components, see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), the fetuses were fixed in 4% PFA for 24 hr at 4°C. Samples were then additionally fixed and dehydrated by exchanging the fixative and washing solutions to incrementally increasing ethanol concentrations (30%, 50%, 70%) with 2 days in each concentration to minimize the shrinkage of tissues. To start the contrasting procedure, the embryos were firstly incubated in ethanol-methanol-water mixture (4:4:3) for 1 hr and then transferred for 1 hr into 80% and 90% methanol solution. The staining procedure was then performed for 10 days in 90% methanol 1.5% PTA solution (changed every day with fresh solution) to ensure optimal penetration of the contrast agent. Staining was followed by rehydration of the samples in methanol-grade series (90%, 80%, 70%, 50% and 30%) and stored in sterile distilled water. The samples were placed in polypropylene tubes and embedded in 1% agarose gel to avoid movement artefacts during measurements. μCT scanning was performed using laboratory system GE Phoenix v\|tome\|x L 240 (GE Sensing and Inspection Technologies GmbH, Hamburg, Germany), equipped with a nanofocus X-ray tube with maximum power of 180 kV/15 W and a flat panel detector DXR250 with 2048 × 2048 pixel2, 200 × 200 µm^2^ pixel size. The μCT scan was carried out at 60 kV acceleration voltage and 200 µA tube current with voxel size of 5.7 μm for all samples. The beam was filtered by a 0.2 mm aluminium filter. The 2200 projections were taken over 360° with exposure time of 900 ms. The tomographic reconstructions were done using the software GE phoenix datos\|x 2.0 (GE Sensing and Inspection Technologies GmbH) and data segmentations and visualizations were performed by combination of software VG Studio MAX 2.2 (Volume GraphicsGmbH, Heidelberg, Germany) and Avizo 7.1 (Thermo Fisher Scientific, Waltham, MA) according to ([@bib87]). The interactive 3D PDFs were set up using 3D PDF maker software.

Imaging {#s4-4}
-------

Images were acquired using the following systems: a Zeiss Axio-plan equipped with an Apotome, a Zeiss stereo zoom microscope V16 or a Zeiss LSM 700 laser-scanning confocal microscope with ZEN software (Carl Zeiss, Oberkochen, Germany). For whole-mount rendering, acquired Z-stacks were 3D reconstructed using Imaris software. All images were assembled in Adobe Photoshop (Adobe Systems, San Jose, CA).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Unique morphogenetic signatures define mammalian neck muscles and associated connective tissues\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Didier Stainier as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Robert Knight (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript examines the complex lineage and genetic regulation of the muscles in the lower head and neck. To characterize lineage, Heude et al. use mouse lines expressing Cre under the control of relatively well-characterised regulatory elements expressed in subsets of the musculature (*Islet1, Mesp1, Pax3*), the neural crest (*Wnt1*) and trunk lateral mesoderm (*Prx1*). They also examine the phenotype of these head and neck muscles in mice lacking *Tbx1* and *Pax3*. They focus on the cucullaris muscles that connect head and neck skeletal elements. This is interesting from an evolutionary perspective as an essential adaptation of gnathostomes allowing movement of the head relative to the body, and also because certain genetic syndromes differentially affect muscles in the head and neck. The origin of this muscle group has so far been controversial. The main findings of this work are that differential expression of *Mesp1, Islet1* and *Pax3* distinguish the head, neck and shoulder muscles, and that the cucullaris originates from branchiomeric (head) paraxial mesoderm, not trunk lateral mesoderm as previously suggested. *Tbx1* is essential for subsets of head-derived muscle while *Pax3* is required for anterior somite-derived muscle.

This is an excellent study of some complex developmental anatomy, presented in a generally beautifully clear and informative way. The results are significant from an evolutionary perspective and relevant to mechanisms that may underlie various musculoskeletal abnormalities in humans. The three-dimensional micro-CT scans presented as interactive PDFs are particularly informative and an ideal way to display complex data of this type -- the sections can display only a small fraction of this information.

Essential revisions:

The authors are requested to clarify the following issues:

1\) Figure 7A displays a hypothetical early origin of the head and neck muscles that is not presented in the data. It crucially shows bilateral \'fingers\' of cranial paraxial mesoderm sitting immediately lateral to somites 1-3, with lateral mesoderm situated more lateral to this. Is there any reason why there are no stained embryos of this stage (or even at E9.5) in the series presented in Figure 1? Without this, it could be argued that the controversial question of paraxial versus lateral plate mesoderm origin of the cucullaris muscle has not been completely resolved. For example *Prx1* may not be expressed in a small subset of lateral plate mesoderm corresponding to future cucullaris, or conversely *Mesp1/Islet1* may secondarily be expressed in a cucullaris anlage that shares a lineage origin with trunk lateral plate mesoderm. If the possibility of a lateral mesoderm origin of cucullaris muscle cannot be ruled out by the current approach, this should be acknowledged in the text.

2\) Please indicate how expression of the constitutive reporters of *Mesp1*, a subset of *Mef2c, Pax3* and *Islet1* expression is affected in the *Tbx1* and *Pax3* mutant mice that are described later in the paper, as this could allow expression of the reporters to be correlated with muscle phenotypes and so make the association between expression and phenotypic outcome clearer. Please also comment on whether the expression of Islet1 in somitic myogenic cells is dependent on *Tbx1* or *Pax3* during early stages of muscle formation.

3\) The use of *Pax3* transgenic line for tracking somitic mesoderm may complicate analysis as it is also expressed in CNCC. The authors note this in the third paragraph of the subsection "Distinct myogenic programs define neck muscle morphogenesis" as they observe a contribution of *Pax3*-expressing cells to the cucullaris but do not address this point further. As a central tenet of the paper is that there is no somite-derived contribution to the cucullaris this should be addressed by comparing *Pax3* reporter expression to NCC markers, since an alternative interpretation is that there is a contribution of somite-derived cells to this muscle that migrate to the anlage after E10.5.

10.7554/eLife.40179.029

Author response

> Essential revisions:
>
> The authors are requested to clarify the following issues:
>
> 1\) Figure 7A displays a hypothetical early origin of the head and neck muscles that is not presented in the data. It crucially shows bilateral \'fingers\' of cranial paraxial mesoderm sitting immediately lateral to somites 1-3, with lateral mesoderm situated more lateral to this. Is there any reason why there are no stained embryos of this stage (or even at E9.5) in the series presented in Figure 1? Without this, it could be argued that the controversial question of paraxial versus lateral plate mesoderm origin of the cucullaris muscle has not been completely resolved. For example Prx1 may not be expressed in a small subset of lateral plate mesoderm corresponding to future cucullaris, or conversely Mesp1/Islet1 may secondarily be expressed in a cucullaris anlage that shares a lineage origin with trunk lateral plate mesoderm. If the possibility of a lateral mesoderm origin of cucullaris muscle cannot be ruled out by the current approach, this should be acknowledged in the text.

The hypothetical early origin of postcranial CPM extension has been proposed on the basis of our results and data reported previously. Unfortunately, there are no specific markers or reporters available to date to trace the early CPM presented in Figure 7A. Our genetic lineage analysis at later stages, in combination with previous work involving innervation studies, grafting experiments, and retrospective clonal analyses indicate that the mesoderm adjacent to the 3 first somites correspond to a posterior branchiomeric population in the early tetrapod embryo (see also Couly et al., Development, 1992). The analysis of the *Prx1* lineage, that appears to define the trunk LPM field, corroborates that the cucullaris muscles are clonally related to the posterior branchiomeric muscles as shown previously through retrospective clonal analysis (Lescroart et al., 2015). We have modified the Discussion to clarify this point (subsection "Branchiomeric origin of cucullaris-derived muscles", first paragraph). Moreover, *Mesp1* does not seem to be secondarily expressed in the cucullaris anlagen. We propose that *Mesp1* activation in the nascent mesoderm during gastrulation is more likely defining both CPM and anterior somites.

> 2\) Please indicate how expression of the constitutive reporters of Mesp1, a subset of Mef2c, Pax3 and Islet1 expression is affected in the Tbx1 and Pax3 mutant mice that are described later in the paper, as this could allow expression of the reporters to be correlated with muscle phenotypes and so make the association between expression and phenotypic outcome clearer. Please also comment on whether the expression of Islet1 in somitic myogenic cells is dependent on Tbx1 or Pax3 during early stages of muscle formation.

Expression of the constitutive reporters in *Tbx1* and *Pax3* mutants has not been analysed in the present study. However, based on lineage analyses and anatomical descriptions, we have defined the genetic embryological origin of the different head/neck/pectoral muscles analysed in mutant foetuses (Figures 5-6, see also our new Figure 7---figure supplement 1). Please find the revised Table 2 that now highlights the myogenic lineages used for the development of the muscle groups, correlating lineage analysis and phenotypic outcomes. Please refer to the colour codes used for the different myogenic programs reported in the main Figures (1, 2, 3, 6, 7), in Figure 7---figure supplement 1 and in the 3D interactive PDFs (Supplementary files 1-3).

To address *Islet1* contribution to the somitic mesoderm, we have modified Figure 1---figure supplement 2C. The results now show that *Islet1* expression is observed in *Pax3*-derived cells in the precursor of the cutaneous maximus and latissimus dorsi somitic muscles (*clp*), completing information reported in Table 1 (footnote \*\*). We have now modified the Results section accordingly (subsection "Distinct myogenic programs define neck muscle morphogenesis", third paragraph). Moreover, we describe in the Discussion that these muscles depend on a specific myogenic program implicating *Pax3* and *Islet1* genes and that they are absent in *Pax3* mutants (subsection "A unique genetic program for somite-derived neck muscles", third paragraph). In contrast, *Tbx1* expression has never been reported during early somitic muscle development, indicating that *clp* formation is dependent on *Islet1* and *Pax3* but not on *Tbx1*.

> 3\) The use of Pax3 transgenic line for tracking somitic mesoderm may complicate analysis as it is also expressed in CNCC. The authors note this in the third paragraph of the subsection "Distinct myogenic programs define neck muscle morphogenesis" as they observe a contribution of Pax3-expressing cells to the cucullaris but do not address this point further. As a central tenet of the paper is that there is no somite-derived contribution to the cucullaris this should be addressed by comparing Pax3 reporter expression to NCC markers, since an alternative interpretation is that there is a contribution of somite-derived cells to this muscle that migrate to the anlage after E10.5.

To address this point, we have added an analysis of the *Pax3* and *Mesp1* contributions to the perinatal trapezius at high magnification (Figure 3---figure supplement 4C-D). This new result demonstrates that the *Pax3*-derived cells in the trapezius correspond to the Tcf4-positive fibroblast population associated with myofibres, similar to that observed in the cranial masseter and tongue muscles, that are composed of NCC-derived connective tissue (Figure 3---figure supplement 2A-B', Figure 3---figure supplement 4A-B, G). We have modified the Results section accordingly (subsection "Dual neural crest and mesodermal origins of neck connective tissues", third paragraph). Taken together, our results exclude the possibility of a *Pax3* lineage contribution to cucullaris myofibres.
